Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
William Shell currently holds 664,764 shares of Targeted Medical Pharma, Inc. (TRGM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William Shell has been a net buyer of TRGM stock. They have purchased $269.2K and sold $94.8K worth of shares.
William Shell's most recent insider trade was on May 28, 2014, when they sold 2,000 shares at $0.60 per share.
William Shell serves as Executive at Targeted Medical Pharma, Inc. (TRGM). They have executed 50 insider transactions totaling $364.0K over their tenure at the company.
William Shell holds the position of Executive at Targeted Medical Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
William Shell has shown a buying trading pattern, with $269.2K in total purchases and $94.8K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by William Shell was on Apr 10, 2014, when they sold $90.0K worth of TRGM shares. This transaction involved 150,000 shares at $0.60 per share.
William Shell currently owns 664,764 shares of Targeted Medical Pharma, Inc. (TRGM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of William Shell's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. William Shell has 50 Form 4 filings on record as an insider at Targeted Medical Pharma, Inc..
Set alerts for William Shell and 40,000+ other insiders.